These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Yang M; Zhong WW; Srivastava N; Slavin A; Yang J; Hoey T; An S Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6027-32. PubMed ID: 15837931 [TBL] [Abstract][Full Text] [Related]
11. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules. Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231 [TBL] [Abstract][Full Text] [Related]
12. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis. Budd DC; Qian Y Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745 [TBL] [Abstract][Full Text] [Related]
13. Oleic acid enhances the motility of umbilical cord blood derived mesenchymal stem cells through EphB2-dependent F-actin formation. Jung YH; Lee SJ; Oh SY; Lee HJ; Ryu JM; Han HJ Biochim Biophys Acta; 2015 Aug; 1853(8):1905-17. PubMed ID: 25962624 [TBL] [Abstract][Full Text] [Related]
14. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme. Tabuchi S Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470 [TBL] [Abstract][Full Text] [Related]
15. Atx regulates skeletal muscle regeneration via LPAR1 and promotes hypertrophy. Ray R; Sinha S; Aidinis V; Rai V Cell Rep; 2021 Mar; 34(9):108809. PubMed ID: 33657371 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells. Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616 [TBL] [Abstract][Full Text] [Related]
17. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984 [TBL] [Abstract][Full Text] [Related]
18. Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications. Laface C; Ricci AD; Vallarelli S; Ostuni C; Rizzo A; Ambrogio F; Centonze M; Schirizzi A; De Leonardis G; D'Alessandro R; Lotesoriere C; Giannelli G Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062979 [TBL] [Abstract][Full Text] [Related]
19. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Okudaira S; Yukiura H; Aoki J Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246 [TBL] [Abstract][Full Text] [Related]
20. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]